Alternative Medicine Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Alternative Medicine Times.

Press releases published on September 29, 2026

Sep. 29, 2026

Weight Watchers and Google Health Enterprise Launch New Collaboration to Enhance Engagement and Outcomes in Weight Health Programs

Indeterminate GlobeNewswire

Sep. 29, 2026

New research reveals a great divide in beauty, health & wellness, with executives and consumers at odds

Indeterminate GlobeNewswire

Sep. 29, 2026

Phathom Pharmaceuticals Announces Initiation of Registrational Phase 3 Study of VOQUEZNA® (vonoprazan) for As-Needed Treatment of Non-Erosive GERD

Indeterminate GlobeNewswire

Sep. 29, 2026

Noah Medical’s Galaxy System Enters Commercial Use in Asia with First Procedure Completed in Hong Kong

Indeterminate GlobeNewswire

Sep. 29, 2026

Apyx Medical Announces New Clinical Study Demonstrating Renuvion®’s Impact on Skin Quality

Indeterminate GlobeNewswire

Sep. 29, 2026

NewAmsterdam Pharma Doses First Participant in Phase 2b SPINOZA Trial Evaluating Obicetrapib in Preclinical Alzheimer’s Disease

Indeterminate GlobeNewswire

Sep. 29, 2026

Fetch Pet Insurance Launches Fetch Online Vet Powered by Vetster, With No Out-of-Pocket Costs or Claims to File

Indeterminate GlobeNewswire

Sep. 29, 2026

Tectonic Therapeutic Announces Favorable Phase 1 Safety, Tolerability and PK Results for TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia (HHT)

Indeterminate GlobeNewswire

Sep. 29, 2026

Claris Bio Announces Oral Presentations at the American Academy of Ophthalmology (AAO) 2026 Annual Meeting and Eyecelerator @ AAO

Indeterminate GlobeNewswire

Sep. 29, 2026

Sutro Biopharma Appoints Lucas Donigian as Senior Vice President, Business Development

Indeterminate GlobeNewswire

Sep. 29, 2026

Corbus Pharmaceuticals Announces First Patient Dosed in TEMPO-1 Registrational Study of CRB-701 in Patients with 2L+ Oropharyngeal Cancer

Indeterminate GlobeNewswire

Sep. 29, 2026

EMS Innovations’ The RISER Named “Caregiver Support Product of the Year” In 2026 Senior Innovation Awards

Indeterminate GlobeNewswire

Sep. 29, 2026

Precision Optics to Participate in the Lytham Partners Fall 2026 Investor Conference

Indeterminate GlobeNewswire

Sep. 29, 2026

IMUNON Converts $1.2 Million of Debt-to-Equity

Indeterminate GlobeNewswire

Sep. 29, 2026

Glass House Brands Announces Planned Retirement of Chief Financial Officer

Indeterminate GlobeNewswire

Sep. 29, 2026

Knight Therapeutics Enters into Exclusive Distribution Agreement with Kyowa Kirin International for Poteligeo® (Mogamulizumab)

Indeterminate GlobeNewswire

Sep. 29, 2026

Thérapeutique Knight conclut une entente de distribution exclusive avec Kyowa Kirin International pour Poteligeo® (Mogamulizumab)

Indeterminate GlobeNewswire

Sep. 29, 2026

Cognition Therapeutics Schedules a Type C Meeting with FDA to Align on Endpoints for Phase 3 Trial of Zervimesine (CT1812) in DLB

Indeterminate GlobeNewswire

Sep. 29, 2026

Cartesian Therapeutics Announces Additional Retreatment Data for Descartes-08 Highlighting Deep and Durable Responses in Patients with Myasthenia Gravis

Indeterminate GlobeNewswire

Sep. 29, 2026

Cellectar Biosciences to Present Compelling Efficacy Data from Phase 2 CLOVER WaM Subset Analysis of Iopofosine I 131 in Patients Refractory/Resistant to BTK Inhibitor Therapy at International Workshop for Waldenström Macroglobulinemia

Indeterminate GlobeNewswire